How to appeal a Repatha denial
The short answer
Plans usually deny Repatha because the request did not show that statins were tried long enough, or did not include LDL cholesterol results above the plan's cutoff. Get the plan's written criteria, then send dated lab results, every cholesterol drug you tried with doses and dates, and records of any statin side effects.
- StartThe denial letterFind what was denied, the reason, and the deadline to appeal.
- Step 1Appeal to your planMost plans give you 60 to 180 days to ask. The plan reviews its own decision.
- Step 2Go outside the planIf it says no again, someone outside the plan can decide: an independent reviewer, a hearing, or a federal office.
Can’t wait? If waiting could seriously harm your health, ask for a fast appeal. Most plans must decide within 72 hours.
What Repatha is approved for
Repatha (evolocumab) is a PCSK9 inhibitor injection. As of November 2026 its FDA label lists these uses:
- Reducing the risk of major cardiovascular events, such as heart attack and stroke, in adults at increased risk.
- Lowering LDL cholesterol, along with diet and exercise, in adults with high cholesterol.
- Lowering LDL in adults and children 10 and older with inherited high cholesterol (heterozygous or homozygous familial hypercholesterolemia).
Why plans deny Repatha
One insurer's national policy recommends prior authorization for Repatha. For people with heart or blood-vessel disease, it asks for:
- A qualifying diagnosis, such as a past heart attack, stroke, coronary artery disease or peripheral artery disease.
- At least 8 continuous weeks on the highest statin dose you can tolerate, with LDL still 55 mg/dL or higher afterward.
- Or proof you cannot take statins: rhabdomyolysis, or muscle symptoms on both atorvastatin and rosuvastatin that went away when each was stopped.
For inherited high cholesterol, the policy looks for an untreated LDL of 190 mg/dL or more, among other options. Denials often come from missing dates, a single statin trial, or lab results taken before treatment instead of after.
Reading the denial
Job-based plans must name the specific plan provision behind a denial, and you can ask for a free copy of the criteria. "Criteria not met" means the plan wanted more medical proof; see prior authorization denials. "Step therapy" or "try a preferred product first" means the plan wants another drug tried; see step therapy denials. "Non-formulary" means Repatha is not on the drug list, which calls for a formulary exception. Check your plan's drug list to see what it prefers.
What your doctor's letter should document
Ask for a letter of medical necessity that answers each criterion, in order, with dated records:
- Each heart or blood-vessel diagnosis, with diagnosis codes and dates.
- LDL results with dates, before treatment and on your current drugs.
- Every statin and other cholesterol drug tried, with dose, dates and results.
- Statin side effects: which drug, what happened, and whether it went away when stopped.
- Family history or genetic test results for inherited high cholesterol.
Ask the plan for the written criteria it used. Job-based plans must name the specific plan provision behind a denial and give you a free copy of any criteria they relied on. File the internal appeal within 180 days of the denial.
If Repatha is not on the drug list, ask for a formulary exception instead of, or alongside, the appeal. Your doctor generally confirms that covered drugs have not worked, will not work as well, or are likely to cause harm. Individual and small-group plans must decide a standard request within 72 hours and an expedited one within 24 hours, and a denial can go to an independent reviewer. See formulary exception letters.
If the plan upholds a denial that turned on medical judgment, you can ask for external review within 4 months of the final decision. Your insurer has to accept the reviewer’s decision.
Medicare, Medicaid and manufacturer help
With a Medicare drug plan, ask for a coverage determination or exception. Your prescriber must provide a statement explaining the medical reason. The plan must decide within 72 hours, or 24 hours if expedited, and Part D exceptions can also cover step therapy and dose limits. You have 65 days to appeal a denial. See Part D appeals.
State Medicaid programs may require prior authorization for any covered drug. See Medicaid appeals.
Amgen offers a Repatha Co-Pay Card through Amgen SupportPlus for eligible patients.
Questions people ask
Do I have to try statins before Repatha?
Usually. One policy asks for 8 weeks of a maximally tolerated statin with LDL still above its cutoff, unless you are statin-intolerant under its definition.
What counts as statin intolerance for Repatha?
Plans define it narrowly. One policy accepts rhabdomyolysis, or muscle symptoms on both atorvastatin and rosuvastatin that resolved when each was stopped.
Insurance stopped covering Repatha after I'd been on it. What can I do?
First find out why: a lapsed prior authorization, a renewal that asked for proof the drug is working, or a drug-list change. Ask your doctor to resubmit with current records. In individual and small-group plans, being in the middle of a course of treatment on a non-formulary drug qualifies for a 24-hour expedited exception. Medicare drug plans must offer a temporary supply in the first 90 days under a new plan, and that process also covers current enrollees affected by formulary changes.
What if my Repatha appeal is denied?
If the denial turned on medical judgment, you can ask for external review by an independent reviewer within 4 months of the plan's final decision. A denied formulary exception in an individual or small-group plan can also go to independent review. With Medicare Part D, if the plan upholds its denial you have 60 days to ask a Part D Independent Review Entity to reconsider; see Part D appeals.
Sources
- National Library of Medicine (DailyMed): REPATHA (evolocumab) prescribing information (DailyMed)
As an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in
- Cigna Healthcare: Hyperlipidemia – PCSK9 Inhibitors – Repatha Prior Authorization Policy (Cigna National Formulary, review date 03/04/2026)
Prior Authorization is recommended for prescription benefit coverage of Repatha.
- eCFR (Office of the Federal Register): 29 CFR 2560.503-1 -- Claims procedure
Reference to the specific plan provisions on which the determination is based
- HealthCare.gov: Getting prescription medications
Visit your insurer’s website to review a list of prescriptions your plan covers
- HealthCare.gov: Internal appeals
You must file your internal appeal within 180 days (6 months) of receiving notice that your claim was denied.
- eCFR (Office of the Federal Register): 45 CFR 156.122 -- Prescription drug benefits
A health plan must make its determination on a standard exception and notify the enrollee or the enrollee's designee and the prescribing physician (or other prescriber, as appropriate) of its coverage determination no later than 72 hours following receipt of the request.
- HealthCare.gov: External Review
You must file a written request for an external review within 4 months after the date you receive a notice or final determination from your insurer that your claim has been denied.
- Medicare.gov: Appeals in a Medicare drug plan
If you're asking for an exception, your prescriber must provide a statement explaining the medical reason why the exception should be approved.
- eCFR (Office of the Federal Register): 42 CFR 423.568 -- Standard timeframe and notice requirements for coverage determinations
but no later than 72 hours after receipt of the physician's or other prescriber's supporting statement
- eCFR (Office of the Federal Register): 42 CFR 423.572 -- Timeframes and notice requirements for expedited coverage determinations
but no later than 24 hours after receipt of the physician's or other prescriber's supporting statement
- eCFR (Office of the Federal Register): 42 CFR 423.578 -- Exceptions process
An exception to a plan's coverage policy that causes a Part D prescription drug not to be covered because of cost utilization tools, such as a requirement for step therapy, dosage limitations, or therapeutic substitution.
- Legal Information Institute, Cornell Law School: 42 U.S. Code § 1396r-8 - Payment for covered outpatient drugs
A State may subject to prior authorization any covered outpatient drug
- Amgen: Repatha Co-Pay Card
Use your Repatha® (evolocumab) Co-Pay Card Today
- eCFR (Office of the Federal Register): 42 CFR 423.120 -- Access to covered Part D drugs
Ensure access to a temporary supply of drugs within the first 90 days of coverage under a new plan.
This page is general information about appeal rules in the United States. It is not legal or medical advice. Rules can change, and your plan’s documents and your denial letter control the dates that apply to you.